Up next

Autoplay

Nab-paclitaxel and gemcitabine in soft tissue sarcoma: trial update

1 Views • 07/18/23
Share
Embed
administrator
administrator
Subscribers
0

Speaking from the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain, Yannis Metaxas, MD, Cantonal Hospital Grison, Chur, Switzerland, discusses the results from the phase I part of the phase I/II SAKK 57/16 trial (NCT03524898). This study investigated nab-paclitaxel and gemcitabine in soft tissue sarcoma.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay